Log In
BCIQ
Print this Print this
 

DA-3880

  Manage Alerts
Collapse Summary General Information
Company Dong-A Socio Holdings Co. Ltd.
Description Biosimilar of darbepoetin alfa, an erythropoiesis stimulating protein
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationAnemia
Indication DetailsTreat anemia; Treat anemia associated with chronic renal failure
Regulatory Designation
PartnerDong-A ST Co. Ltd.;
Sanwa Kagaku Kenkyusho Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today